Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis

NCT00117325 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00117325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00117325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 4 Week Randomized, Double Blind, Placebo Controlled Study of GW685698X Aq Nasal Spray 100mcg QD in Adults and Adolescents With Vasomotor Rhinitis
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
July 11, 2005
Completion date
February 9, 2006
Enrollment
352 (actual)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

rhinitis, vasomotor